Bacteriostatic Water for Injection Market Will Witness Rapid Growth Driven By Technological Advancements in Medical Injection Processes
Bacteriostatic water for injection is a sterile and pyrogen-free solution that is commonly used to reconstitute powdered medicines for subsequent parenteral administration of drugs in patients. Growing demand for sterile water to dilute drug formulations and reconstitute powders before injection administration is aiding industry growth.
Bacteriostatic water helps prevent contamination and bacterial growth within diluted drug solutions. It is available in pre-filled syringes and vials for on-site reconstitution and administration of a wide range of antibiotics, anesthetics, and chemotherapeutics. Rapid scale-up of pharmaceutical manufacturing activities and launch of new injectable drugs has spurred usage of bacteriostatic water. Additionally, technological advancements in pharmaceutical packaging and medical processes involving wider application of injections are fueling market expansion.
The global bacteriostatic water for injection market size is estimated to be valued at US$ 1.22 Bn in 2024 and is expected to exhibit a CAGR of 7.8% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Bacteriostatic Water For Injection Market Demand are Baxter International Inc., Fresenius Kabi AG, Hospira, Inc., B. Braun Melsungen AG, Eagle Pharmaceuticals, Inc., Sagent Pharmaceuticals, Inc., Baxter Healthcare Corporation, MediPharma, AstraZeneca, Hikma Pharmaceuticals PLC, Amgen Inc., Teva Pharmaceutical Industries Ltd., Sandoz (a Novartis division), Merck & Co., Inc., GlaxoSmithKline PLC, Cipla Limited, Sun Pharmaceutical Industries Ltd., Roche Holding AG, Alvogen, Zydus Cadila.
Rising geriatric population suffering from chronic diseases and growth in healthcare expenditure creates high demand for parenteral drugs providing opportunities to bacteriostatic water producers.
Technological advancements in pharmaceutical processing and medical devices allow for wider incorporation of bacteriostatic water in pre-filled syringes and novel drug delivery systems.
Market Drivers
Increasing incidence of infectious diseases and chronic conditions is raising consumption of broad-spectrum antibiotics and biologic injectables, major end-users of bacteriostatic water for reconstitution and dilution purposes. Growing demand from pharmaceutical manufacturing companies is a key driver of Bacteriostatic Water For Injection Market Growth over the forecast period.
Get more insights on Bacteriostatic Water for Injection Market
Explore More Articles Related Medical Tricorder Market
Discover the Report for More Insights, Tailored to Your Language
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian